Skip to main content

Table 1 Patient characteristics

From: A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis

Number of patients 17
Age (yr) 22.8 ± 10.5
Children (between 2 and < / = 12) 3
Adolescents (between > 12 and < / = 21) 6
Adults (> 21) 8
Male 13
Weight (kg) 55.3 ± 21.1
Single dose of IR-Cysteamine (Cystagon®) 550.7 ± 159.6
Single dose of DR-Cysteamine (Procysbi®) 741.2 ± 203.5